| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000049521 |
| Receipt No. | R000056304 |
| Scientific Title | Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema |
| Date of disclosure of the study information | 2022/11/16 |
| Last modified on | 2022/11/16 (Ver. 1) |
| Basic information | ||
| Public title | Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema | |
| Acronym | Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema | |
| Scientific Title | Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema | |
| Scientific Title:Acronym | Evaluation of microaneurysms using intravitreal faricimab for diabetic macular edema | |
| Region |
|
|
| Condition | ||
| Condition | diabetic macular edema | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluating microaneurysms before and after treatment of farisimab in diabetic macular edema |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in the number of microaneurysms |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who received farisimab for DME from the Department of Ophthalmology, University of Fukui Hospital between August 1, 2022 and December 31, 2024 | |||
| Key exclusion criteria | Patients who refused to be enrolled in this study.
Patients who were unable to undergo ophthalmologic examination due to cognitive or physical factors. Other cases in which the principal investigator determines that the patient is inappropriate as a research subject. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | university of Fukui Hospital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 9101193 | ||||||
| Address | 23-3, matcuoka shimoaituki, eiheiji-cho, yoshida-gun, Fukui | ||||||
| TEL | 0776-61-8403 | ||||||
| ytakamura@hotmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | university of Fukui Hospital | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 9101193 | ||||||
| Address | 23-3, matcuoka shimoaituki, eiheiji-cho, yoshida-gun, Fukui | ||||||
| TEL | 0776-61-8403 | ||||||
| Homepage URL | |||||||
| yyutaka@u-fukui.ac.jp | |||||||
| Sponsor | |
| Institute | university of Fukui Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | university of Fukui Hospital |
| Address | 23-3, matcuoka shimoaituki, eiheiji-cho, yoshida-gun, Fukui |
| Tel | 0776-61-8403 |
| ytakamura@hotmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | nothing particular |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056304 |